Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: WY NONMETROPOLITAN AREA — September 2026
Wyoming nonmetro life sci pay falls as labor pool tightens further.
Metro advertised pay dropped significantly for five of six tracked life sciences roles even as nonmetro unemployment held at lows of 1.8% in Teton County, pointing to a labor market too thin to support competitive bidding.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Nonmetro county unemployment range: 1.8%–4.0% — Teton County low vs Niobrara County high, Aug 2026
- Statewide unemployment: 3.0% — vs 4.1% US rate, unchanged July to August 2026
- Research Scientist advertised pay: $127,063 metro — Down significantly vs $131,354 national, up
- Initial UI claims: 855 claims — 2nd-fewest for any August since 2007
Key takeaways
Local pay cuts across skilled roles look like capitulation, not strategy.
Research Scientist, Clinical Data Manager, and Biostatistician advertised pay all fell significantly in the metro even as national medians rose or held steady. This divergence is consistent with employers scaling back role scope or seniority targets rather than genuinely competing for scarce specialized talent.
Clinical Research Associate pay is the one bright spot worth tracking.
Metro CRA pay rose moderately to $121,342, above the rising national median of $90,956 — an unusual local premium that may reflect a small number of employers bidding aggressively for scarce clinical operations talent in a county-level labor pool with almost no bench strength.
Regulatory Affairs Specialist pay drop collides with a national bottleneck.
Metro advertised pay for Regulatory Affairs Specialist fell significantly to $88,634 while national demand for regulatory talent intensifies amid EU MDR and FDA pathway changes. Organizations should evaluate whether this reflects genuine reduced need locally or a mispriced requisition that will sit unfilled against national competition.
Tight labor supply strengthens the case for CDMO/CRO reliance.
With nonmetro unemployment as low as 1.8% in Teton County and statewide job growth near flat, building internal manufacturing, quality, or specialized scientific headcount in Wyoming carries longer time-to-fill risk than in denser biotech hubs. Build-vs-outsource decisions should weight local scarcity more heavily than national average fill times.
Median advertised pay by role — WY NONMETROPOLITAN AREA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $109,700 | $127,063 | $134,534 | Significant decline | $131,354 |
| Clinical Research Associate | $102,500 | $121,342 | $127,273 | Moderate increase | $90,956 |
| Lab Technician * | $37,261 | $37,853 | $37,853 | Significant decline | $47,402 |
| Regulatory Affairs Specialist * | $87,596 | $88,634 | $91,265 | Significant decline | $104,000 |
| Clinical Data Manager * | $96,908 | $105,049 | $106,909 | Significant decline | $123,031 |
| Biostatistician | $93,655 | $139,754 | $145,002 | Significant decline | $133,322 |
| Validation Engineer | — | — | — | No data | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Wyoming's nonmetro counties remain exceptionally tight, with unemployment ranging from 1.8% in Teton County to 4.0% in Niobrara County against a statewide 3.0% rate, while total nonfarm employment grew just 0.2% year-over-year through August 2026. Initial unemployment insurance claims hit the second-lowest August total since 2007, signaling employers are holding onto workers rather than cutting — but also confirming almost no slack exists in the labor pool for life sciences employers trying to scale.
What it means
Scarcity of labor supply across Wyoming's nonmetro counties, combined with a thin existing life sciences employer base (roughly 88 open biotech roles statewide and a single national biotech board listing), means internal hiring for specialized R&D, clinical, or quality functions faces structural headwinds that no amount of posted pay will quickly solve. Falling advertised pay for Research Scientist, Clinical Data Manager, and Biostatistician roles locally — even as these same roles rise nationally — suggests employers here are either downgrading role scope or losing the leverage to compete on cash compensation alone. Consider evaluating whether open regulatory, quality, or biostatistics requisitions are better filled through CRO/CDMO partnerships or remote-first arrangements rather than continued local recruitment against a 3.0% unemployment floor.
Looking ahead
Expected: September 2026 Wyoming unemployment data releases October 20-21 — watch whether statewide and county-level tightness (particularly Teton and Albany counties) persists or eases, directly affecting time-to-fill assumptions for any planned R&D or quality hires.
Worth watching: Metro advertised pay fell significantly across five of six tracked life sciences roles this month while national medians generally held or rose — confirm whether this is a one-month data anomaly or a sustained local repricing before resetting offer ranges.
Emerging pressure point: National biopharma layoffs (BioMarin, Bristol Myers) are concentrated in consolidation functions, not execution roles — monitor whether any displaced regulatory or CMC talent becomes available for remote hires into Wyoming-based teams, a potential pool unlikely to be found locally.
Early indicator: Hoskinson Biotechnology in Gillette remains one of the few visible nonmetro life sciences employers advertising clinical lab scientist roles at $52K-$85K; watch whether its hiring pace signals broader lab-capacity expansion or remains an isolated data point.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.